210 related articles for article (PubMed ID: 20069432)
1. A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.
Burghaus S; Hölsken A; Buchfelder M; Fahlbusch R; Riederer BM; Hans V; Blümcke I; Buslei R
Virchows Arch; 2010 Mar; 456(3):287-300. PubMed ID: 20069432
[TBL] [Abstract][Full Text] [Related]
2. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.
Hölsken A; Sill M; Merkle J; Schweizer L; Buchfelder M; Flitsch J; Fahlbusch R; Metzler M; Kool M; Pfister SM; von Deimling A; Capper D; Jones DT; Buslei R
Acta Neuropathol Commun; 2016 Feb; 4():20. PubMed ID: 26927026
[TBL] [Abstract][Full Text] [Related]
3. Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?
Hölsken A; Stache C; Schlaffer SM; Flitsch J; Fahlbusch R; Buchfelder M; Buslei R
Pituitary; 2014 Dec; 17(6):546-56. PubMed ID: 24356780
[TBL] [Abstract][Full Text] [Related]
4. Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.
Stache C; Hölsken A; Fahlbusch R; Flitsch J; Schlaffer SM; Buchfelder M; Buslei R
Neuro Oncol; 2014 Jan; 16(2):256-64. PubMed ID: 24305709
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
[TBL] [Abstract][Full Text] [Related]
6. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
Weiner HL; Wisoff JH; Rosenberg ME; Kupersmith MJ; Cohen H; Zagzag D; Shiminski-Maher T; Flamm ES; Epstein FJ; Miller DC
Neurosurgery; 1994 Dec; 35(6):1001-10; discussion 1010-1. PubMed ID: 7885544
[TBL] [Abstract][Full Text] [Related]
7. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
[TBL] [Abstract][Full Text] [Related]
8. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.
Hölsken A; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
Acta Neuropathol; 2010 May; 119(5):631-9. PubMed ID: 20131060
[TBL] [Abstract][Full Text] [Related]
9. Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse model.
Stache C; Hölsken A; Schlaffer SM; Hess A; Metzler M; Frey B; Fahlbusch R; Flitsch J; Buchfelder M; Buslei R
Brain Pathol; 2015 Jan; 25(1):1-10. PubMed ID: 24716541
[TBL] [Abstract][Full Text] [Related]
10. EGFR signaling regulates tumor cell migration in craniopharyngiomas.
Hölsken A; Gebhardt M; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
Clin Cancer Res; 2011 Jul; 17(13):4367-77. PubMed ID: 21562037
[TBL] [Abstract][Full Text] [Related]
11. Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas.
Hölsken A; Kreutzer J; Hofmann BM; Hans V; Oppel F; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
Brain Pathol; 2009 Jul; 19(3):357-64. PubMed ID: 18540944
[TBL] [Abstract][Full Text] [Related]
12. Astrocytoma grade IV (glioblastoma multiforme) displays 3 subtypes with unique expression profiles of intermediate filament proteins.
Skalli O; Wilhelmsson U; Orndahl C; Fekete B; Malmgren K; Rydenhag B; Pekny M
Hum Pathol; 2013 Oct; 44(10):2081-8. PubMed ID: 23791210
[TBL] [Abstract][Full Text] [Related]
13. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
Cao J; Lin JP; Yang LX; Chen K; Huang ZS
Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632
[TBL] [Abstract][Full Text] [Related]
14. MAP2 and nestin co-expression in dysembryoplastic neuroepithelial tumors.
Duggal N; Iskander S; Hammond RR
Clin Neuropathol; 2003; 22(2):57-65. PubMed ID: 12670051
[TBL] [Abstract][Full Text] [Related]
15. Expression of nestin--a stem cell associated intermediate filament in human CNS tumours.
Rani SB; Mahadevan A; Anilkumar SR; Raju TR; Shankar SK
Indian J Med Res; 2006 Sep; 124(3):269-80. PubMed ID: 17085830
[TBL] [Abstract][Full Text] [Related]
16. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.
Sekine S; Shibata T; Kokubu A; Morishita Y; Noguchi M; Nakanishi Y; Sakamoto M; Hirohashi S
Am J Pathol; 2002 Dec; 161(6):1997-2001. PubMed ID: 12466115
[TBL] [Abstract][Full Text] [Related]
17. Can recurrences be predicted in craniopharyngiomas? β-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases.
Guadagno E; de Divitiis O; Solari D; Borrelli G; Bracale UM; Di Somma A; Cappabianca P; Del Basso De Caro M
J Exp Clin Cancer Res; 2017 Jul; 36(1):95. PubMed ID: 28709442
[TBL] [Abstract][Full Text] [Related]
18. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting coexpression of nestin and glial fibrillary acidic protein in primary cultures of astroglial cells with a major participation of nestin(+)/GFAP(-) cells in cell proliferation.
Sergent-Tanguy S; Michel DC; Neveu I; Naveilhan P
J Neurosci Res; 2006 Jun; 83(8):1515-24. PubMed ID: 16612832
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cyst.
Xin W; Rubin MA; McKeever PE
Arch Pathol Lab Med; 2002 Oct; 126(10):1174-8. PubMed ID: 12296753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
